return to news
  1. Modern Diagnostic and Research Centre IPO subscribed 22 times so far on Day 2: 10 key things to know

Market News

Modern Diagnostic and Research Centre IPO subscribed 22 times so far on Day 2: 10 key things to know

Kamal Joshi

3 min read | Updated on January 01, 2026, 15:26 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Modern Diagnostic and Research Centre IPO: The ₹36.89 crore offer is only a fresh issuance of 40,99,200 shares. Funds raised would be utilised for funding capital expenditure for the purchase of medical equipment for laboratories and diagnostic centres, working capital requirements, debt clearance and general corporate purposes.

Modern Diagnostic and Research Centre offers diagnostic and related healthcare test services in India. | Image: mdrcIndia.com

Modern Diagnostic and Research Centre offers diagnostic and related healthcare test services in India. | Image: mdrcIndia.com

Modern Diagnostic and Research Centre IPO: The initial public offering of Modern Diagnostic and Research Centre has been subscribed 22.06 times so far on the second day of bidding on Thursday, January 1. The issue will end on Friday, January 2.

Open FREE Demat Account within minutes!
Join now

It has secured bids for 6,48,09,600 shares compared to 29,37,600 shares on offer, according to the BSE data until 3:20 pm.

Modern Diagnostic and Research Centre IPO: 10 key points to know

  • Modern Diagnostic and Research Centre IPO subscription period: The initial public offering is live from December 31 to January 2.
  • Anchor round: Before the IPO, the company raised ₹10.45 crore from nine anchor investors, including Aarth AIF Growth Fund, SB Opportunities Fund II and Sunrise Investment Trust-Sunrise Investment Opportunities Fund.
  • IPO offer structure: The ₹36.89 crore IPO is only a fresh issuance of 40,99,200 shares.
  • Objectives: Funds raised from the fresh issue would be utilised for funding capital expenditure for the purchase of medical equipment for laboratories and diagnostic centres, working capital requirements, debt clearance and general corporate purposes.
  • Modern Diagnostic and Research Centre IPO price band: The price range has been fixed at ₹118 to ₹124 per share.
  • Modern Diagnostic and Research Centre IPO lot size: A lot consists of 1,600 shares. Individual investors can apply for at least two lots or 3,200 shares.
  • Book-running lead manager: Beeline Capital Advisors is the IPO's book-running lead manager.
  • Registrar: MUFG Intime India serves as the registrar.
  • Modern Diagnostic and Research Centre IPO allotment date: The allotment is expected to be finalised on January 5.
  • Listing date: The listing on the stock exchanges will take place on January 7, 2026.

Modern Diagnostic and Research Centre IPO GMP

According to investorgain.com and media reports, unlisted shares of Modern Diagnostic and Research Centre Ltd are trading at ₹102, reflecting a grey market premium (GMP) of 13.33% over the upper price band of ₹90.

Disclaimer: Grey Market Premium (GMP) is not regulated or recommended by the stock exchanges or SEBI. Upstox does not endorse or facilitate trading in the grey market. Investors are advised to conduct their own research or consult an expert before making any investment decisions.
To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.

To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Kamal Joshi
Kamal Joshi is a business journalist who covers industries, markets, and IPOs. He is passionate about breaking news and enjoys playing tennis, especially flexing his backhand. He was previously associated with Republic TV and LatestLY.

Next Story